The KPNA1 Knockout SK-HEP-1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the SK-HEP-1 human liver adenocarcinoma cell line. This product provides a loss-of-function model for the KPNA1 gene, which encodes importin subunit alpha-1, a key nuclear import receptor. The polyclonal population consists of a heterogeneous pool of edited cells, enabling functional studies without clonal selection artifacts. This knockout model is suitable for investigating KPNA1-dependent nuclear transport mechanisms and their roles in cellular signaling, proliferation, and disease pathogenesis.
The SK-HEP-1 host cell line was originally established from the ascitic fluid of a patient with liver adenocarcinoma and serves as a widely used model for studying hepatocellular carcinoma (HCC) biology. These cells exhibit characteristic features of liver cancer, including dysregulated proliferation and altered signaling pathways. Their human origin and tumorigenic properties make them particularly relevant for translational research in oncology, virology, and immunology.
KPNA1 functions as an adaptor that recognizes classical nuclear localization signals (cNLS) on cargo proteins and facilitates their nuclear import by forming a trimeric complex with importin beta (KPNB1). This complex translocates through the nuclear pore complex (NPC) via interactions with NUP proteins, a process driven by the RanGTPase gradient. CSE1L/CAS mediates the recycling of KPNA1 back to the cytoplasm. The activity of KPNA1 is regulated by upstream signals such as interferon gamma (IFNG), interleukin 6 (IL6), and epidermal growth factor (EGF). Key downstream cargoes include transcription factors STAT1, NFKB, and TP53, which are essential for interferon signaling, inflammatory responses, and cell cycle control.
In the context of SK-HEP-1 liver adenocarcinoma cells, disruption of KPNA1 is expected to impair the nuclear import of these transcription factors, thereby attenuating pathways that promote cancer cell proliferation and survival. For example, defective nuclear translocation of NFKB may reduce the expression of anti-apoptotic genes, while impaired STAT1 import could compromise interferon-mediated anti-viral responses. This makes the KPNA1 knockout model highly valuable for dissecting the role of nucleocytoplasmic trafficking in liver cancer progression and for understanding how perturbed import mechanisms contribute to viral infection susceptibility and autoimmune dysregulation.
Researchers can employ this polyclonal knockout cell population in a variety of experimental applications, including western blotting and immunofluorescence microscopy to confirm KPNA1 ablation and assess the subcellular localization of cargo proteins. Functional assays such as luciferase reporter systems can quantify the transcriptional activity of STAT1 or NFKB, while cell proliferation assays evaluate growth phenotypes. Viral infection studies using hepatitis viruses or other import-dependent pathogens can be performed to model host-pathogen interactions. Additionally, transcriptomic analysis via RNA-seq can reveal global gene expression changes resulting from KPNA1 loss. For further details, please contact Ascent Research.
